Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PPD Discovery Inc.

Division of Pharmaceutical Product Development Inc.
www.ppddiscovery.com

Latest From PPD Discovery Inc.

Division Directors Wanted: Will US FDA Look Outside For New Leaders?

Revamped Office of New Drugs will create many new opportunities for FDA to promote from within. But FDA may also need to recruit from outside for candidates to take on management roles. While that is not typical, there are successful examples.

FDA Leadership

PPD: Discoverizing the CRO Model

A period of rapid growth during the mid-1990s, which included a series of acquisitions and an IPO, distracted PPD's management' from the fundamentals of running their business. And By 1999, CEO Fred Eshelman saw that his company was running the risk of becoming untracked. The problems ranged from project delays to uneven quality to inadequate fiscal management. In response, PPD's leadership implemented a series of measures to address those deficiencies. These efforts, and a little luck, helped PPD weather the two-year CRO slump far better that did its competitors. But PPD is hardly resting on its laurels. With it becoming increasingly apparent that the traditional, pure fee-for service model is obsolete, PPD, like the other major CROs, is moving in to new areas in search of higher margins. PPD is, however, unique in venturing upstream in R&D, while the others have businesses in marketing, web-web-enablement and consulting services. PPD has built an already profitable discovery business designed to generate income from up-front and research support payments, as well as royalty fees and milestones. It's a move that, while perhaps riskier than the tack being taken by the other CROs, could yield far greater rewards.
BioPharmaceutical Strategy

PPD Discovers a Strategy

Drug discovery isn't just another outsourcing business for this CRO--it's a source of new technology and strategies that may speed drugs to market and redefine how CROs profit from it.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pharmaceutical Product Development Inc.
  • Senior Management
  • Bradley B Brown, Pres. & CEO
    Gail McIntyre, PhD, SVP, Research
  • Contact Info
  • PPD Discovery Inc.
    Phone: (919) 485-8000
    PO Box 14608
    Research Triangle Park, NC 27709
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register